Back to Journals » OncoTargets and Therapy » Volume 16

Case report

Partial Response to Crizotinib in a Lung Adenocarcinoma Patient with a Novel FBXO11 (Intergenic)-ALK (Exon 20-29) Fusion

       
Total article views   HTML views PDF downloads Totals
2,131 Dovepress* 2,050+ 79 2,129
PubMed Central* 81 43 124
Totals 2,131 122 2,253
*Since 7 July 2023

View citations on PubMed Central and Google Scholar